XNAS 13 Jul, 2026 5:30 PM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| Subhashis Banerjee | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 9.01 per share. | 19 May 2026 | 7,037 | 144,963 | - | 9.0 | 63,386 | Common Stock |
| Fred Aslan | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 9.01 per share. | 19 May 2026 | 27,116 | 1,535,082 | - | 9.0 | 244,253 | Common Stock |
| Heather Raymon | SVP, Research and Development | Sale of securities on an exchange or to another person at price $ 9.01 per share. | 19 May 2026 | 3,095 | 148,228 | - | 9.0 | 27,879 | Common Stock |
| Christopher Horan | Chief Tech Operations Officer | Sale of securities on an exchange or to another person at price $ 9.01 per share. | 19 May 2026 | 7,002 | 293,450 | - | 9.0 | 63,073 | Common Stock |
| Jennifer Kinsbruner Bush | COO, CLO, Compliance Officer | Sale of securities on an exchange or to another person at price $ 9.01 per share. | 19 May 2026 | 8,790 | 337,920 | - | 9.0 | 79,179 | Common Stock |
| Diego Miralles | President & Head of R&D | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2026 | 77,500 | 77,500 | - | 0 | Common Stock | |
| Diego Miralles | President & Head of R&D | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2026 | 232,500 | 232,500 | - | - | Employee Stock Option (Right to Buy) | |
| Thad Allen Huston | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2026 | 220,000 | 220,000 | - | 0 | Common Stock | |
| Elaine K. Sorg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2026 | 27,500 | 27,500 | - | - | Director Stock Option (Right to Buy) | |
| Christopher Horan | Chief Tech Operations Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.00 per share. | 15 Feb 2026 | 2,187 | 300,452 | - | 4 | 8,748 | Common Stock |
| Jennifer Kinsbruner Bush | COO, CLO, Secy, Compliance Off | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2026 | 117,300 | 350,225 | - | 0 | Common Stock | |
| Jennifer Kinsbruner Bush | COO, CLO, Secy, Compliance Off | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.00 per share. | 15 Feb 2026 | 3,515 | 346,710 | - | 4 | 14,060 | Common Stock |
| Christopher Horan | Chief Tech Operations Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2026 | 117,300 | 302,639 | - | 0 | Common Stock | |
| Heather Raymon | SVP, Research and Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2026 | 46,000 | 152,844 | - | 0 | Common Stock | |
| Fred Aslan | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2026 | 366,850 | 1,576,798 | - | 0 | Common Stock | |
| Fred Aslan | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.00 per share. | 15 Feb 2026 | 14,600 | 1,562,198 | - | 4 | 58,400 | Common Stock |
| Subhashis Banerjee | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2026 | 102,000 | 152,000 | - | 0 | Common Stock | |
| Heather Raymon | SVP, Research and Development | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.00 per share. | 15 Feb 2026 | 1,521 | 151,323 | - | 4 | 6,084 | Common Stock |
| Fred Aslan | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 6.00 per share. | 15 Dec 2025 | 3,187 | 1,209,948 | - | 6 | 19,122 | Common Stock |
| Jennifer Kinsbruner Bush | COO, CLO, Secy, Compliance Off | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Dec 2025 | 14,202 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Heather Raymon | SVP, Research and Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2025 | 67,253 | 106,844 | - | 0 | Common Stock | |
| Heather Raymon | SVP, Research and Development | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Dec 2025 | 18,239 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Christopher Horan | Chief Tech Operations Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Dec 2025 | 77,519 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Christopher Horan | Chief Tech Operations Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2025 | 107,156 | 185,339 | - | 0 | Common Stock | |
| Christopher Horan | Chief Tech Operations Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Dec 2025 | 20,519 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Christopher Horan | Chief Tech Operations Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Dec 2025 | 9,119 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Jennifer Kinsbruner Bush | COO, CLO, Secy, Compliance Off | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Dec 2025 | 41,039 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Jennifer Kinsbruner Bush | COO, CLO, Secy, Compliance Off | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Dec 2025 | 9,119 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Jennifer Kinsbruner Bush | COO, CLO, Secy, Compliance Off | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Dec 2025 | 20,519 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Jennifer Kinsbruner Bush | COO, CLO, Secy, Compliance Off | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2025 | 84,877 | 232,925 | - | 0 | Common Stock | |
| Fred Aslan | Director, President and CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Dec 2025 | 51,463 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Heather Raymon | SVP, Research and Development | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Dec 2025 | 10,259 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Heather Raymon | SVP, Research and Development | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Dec 2025 | 11,399 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Heather Raymon | SVP, Research and Development | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Dec 2025 | 14,819 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Heather Raymon | SVP, Research and Development | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Dec 2025 | 12,539 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Fred Aslan | Director, President and CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Dec 2025 | 26,450 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Fred Aslan | Director, President and CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Dec 2025 | 113,999 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Fred Aslan | Director, President and CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Dec 2025 | 319,331 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Fred Aslan | Director, President and CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Dec 2025 | 100,577 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Fred Aslan | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2025 | 869,136 | 1,213,135 | - | 0 | Common Stock | |
| Fred Aslan | Director, President and CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Dec 2025 | 257,319 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Jennifer Kinsbruner Bush | COO, CLO, Secy, Compliance Off | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.25 per share. | 15 Nov 2025 | 3,055 | 148,048 | - | 3.3 | 9,929 | Common Stock |
| Fred Aslan | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.25 per share. | 15 Nov 2025 | 6,347 | 350,374 | - | 3.3 | 20,628 | Common Stock |
| Fred Aslan | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 3.38 per share. | 15 Nov 2025 | 6,375 | 343,999 | - | 3.4 | 21,522 | Common Stock |
| Heather Raymon | SVP, Research and Development | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.25 per share. | 15 Nov 2025 | 1,375 | 39,591 | - | 3.3 | 4,469 | Common Stock |
| Neha Krishnamohan | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.25 per share. | 15 Nov 2025 | 3,490 | 99,356 | - | 3.3 | 11,343 | Common Stock |
| Christopher Horan | Chief Tech Operations Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.25 per share. | 15 Nov 2025 | 1,899 | 78,183 | - | 3.3 | 6,172 | Common Stock |
| Fred Aslan | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 6.00 per share. | 17 Oct 2025 | 25,500 | 356,721 | - | 6 | 153,000 | Common Stock |
| Brian Daniels | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2025 | 13,750 | 13,750 | - | - | Director Stock Option (Right to Buy) | |
| Elizabeth L. Hougen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2025 | 13,750 | 13,750 | - | - | Director Stock Option (Right to Buy) | |
| Alison Moore | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2025 | 13,750 | 13,750 | - | - | Director Stock Option (Right to Buy) | |
| Diego Miralles | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2025 | 13,750 | 13,750 | - | - | Director Stock Option (Right to Buy) | |
| Laura Stoppel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2025 | 13,750 | 13,750 | - | - | Director Stock Option (Right to Buy) | |
| Daniel G. Baker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2025 | 13,750 | 13,750 | - | - | Director Stock Option (Right to Buy) | |
| Jennifer Kinsbruner Bush | COO, CLO, Secy, Compliance Off | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.13 per share. | 15 May 2025 | 1,937 | 157,512 | - | 2.1 | 4,126 | Common Stock |
| Jennifer Kinsbruner Bush | COO, CLO, Secy, Compliance Off | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.75 per share. | 15 May 2025 | 6,409 | 151,103 | - | 2.8 | 17,625 | Common Stock |
| Christopher Horan | Chief Tech Operations Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.13 per share. | 15 May 2025 | 1,341 | 83,659 | - | 2.1 | 2,856 | Common Stock |
| Christopher Horan | Chief Tech Operations Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.75 per share. | 15 May 2025 | 3,577 | 80,082 | - | 2.8 | 9,837 | Common Stock |
| Neha Krishnamohan | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.75 per share. | 15 May 2025 | 5,813 | 102,846 | - | 2.8 | 15,986 | Common Stock |
| Neha Krishnamohan | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.13 per share. | 15 May 2025 | 1,341 | 108,659 | - | 2.1 | 2,856 | Common Stock |
| Heather Raymon | SVP, Research and Development | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.13 per share. | 15 May 2025 | 745 | 42,605 | - | 2.1 | 1,587 | Common Stock |
| Heather Raymon | SVP, Research and Development | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.75 per share. | 15 May 2025 | 1,639 | 40,966 | - | 2.7 | 4,507 | Common Stock |
| Fred Aslan | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.13 per share. | 15 May 2025 | 4,472 | 412,193 | - | 2.1 | 9,525 | Common Stock |
| Fred Aslan | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.75 per share. | 15 May 2025 | 4,472 | 382,221 | - | 2.8 | 12,298 | Common Stock |
| Fred Aslan | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 2.73 per share. | 15 May 2025 | 25,500 | 386,693 | - | 2.7 | 69,579 | Common Stock |
| Subhashis Banerjee | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Apr 2025 | 50,000 | 50,000 | - | 0 | Common Stock | |
| Subhashis Banerjee | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Apr 2025 | 80,000 | 80,000 | - | - | Employee Stock Option (Right to Buy) | |
| Fred Aslan | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Mar 2025 | 200,000 | 416,665 | - | 0 | Common Stock | |
| Heather Raymon | SVP, Research and Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2025 | 33,350 | 43,350 | - | 0 | Common Stock | |
| Thorsten Graef | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2025 | 60,000 | 80,000 | - | 0 | Common Stock | |
| Jennifer Kinsbruner Bush | COO, CLO, Secy, Compliance Off | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2025 | 86,650 | 159,449 | - | 0 | Common Stock | |
| Christopher Horan | Chief Tech Operations Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2025 | 60,000 | 85,000 | - | 0 | Common Stock | |
| Neha Krishnamohan | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2025 | 60,000 | 110,000 | - | 0 | Common Stock | |
| Daniel G. Baker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2025 | 27,500 | 27,500 | - | - | Director Stock Option (Right to Buy) | |
| Heather Raymon | SVP, Research and Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Sep 2024 | 10,000 | 10,000 | - | 0 | Common Stock | |
| Neha Krishnamohan | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Sep 2024 | 50,000 | 50,000 | - | 0 | Common Stock | |
| Christopher Horan | Chief Tech Operations Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Sep 2024 | 25,000 | 25,000 | - | 0 | Common Stock | |
| Jennifer Kinsbruner Bush | COO, CLO, Secy, Compliance Off | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Sep 2024 | 50,000 | 72,799 | - | 0 | Common Stock | |
| Thorsten Graef | Chief Medical Officer | 12 Sep 2024 | 20,000 | 20,000 | - | 0 | Common Stock | ||
| Yong-Jun Huh | Director | 22 Jul 2024 | 1,666,666 | 3,306,900 | - | 12 | 19,999,992 | Common Stock | |
| Yong-Jun Huh | Director | 22 Jul 2024 | 62,181 | 0 | - | - | Series B Preferred Stock | ||
| Yong-Jun Huh | Director | 22 Jul 2024 | 292,791 | 0 | - | - | Series A Preferred Stock | ||
| Yong-Jun Huh | Director | 22 Jul 2024 | 330,095 | 0 | - | - | Series B Preferred Stock | ||
| Yong-Jun Huh | Director | 22 Jul 2024 | 667,185 | 0 | - | - | Series A Preferred Stock | ||
| Yong-Jun Huh | Director | 22 Jul 2024 | 294,117 | 1,640,234 | - | 10.2 | 2,999,993 | Common Stock | |
| Yong-Jun Huh | Director | 22 Jul 2024 | 330,095 | 1,346,117 | - | - | Common Stock | ||
| Yong-Jun Huh | Director | 22 Jul 2024 | 416,666 | 1,260,512 | - | 12 | 4,999,992 | Common Stock | |
| Yong-Jun Huh | Director | 22 Jul 2024 | 256,316 | 843,846 | - | 10.2 | 2,614,423 | Common Stock | |
| Yong-Jun Huh | Director | 22 Jul 2024 | 62,181 | 587,530 | - | - | Common Stock | ||
| Yong-Jun Huh | Director | 22 Jul 2024 | 292,791 | 525,349 | - | - | Common Stock | ||
| Yong-Jun Huh | Director | 22 Jul 2024 | 667,185 | 1,016,022 | - | - | Common Stock | ||
| Fred Aslan | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jul 2024 | 343,811 | 343,811 | - | - | Employee Stock Option (Right to Buy) | |
| Fred Aslan | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jul 2024 | 228,905 | 228,905 | - | 0 | Common Stock |